Hsp70 modulates immune response in pancreatic cancer through dendritic cells

References

• Torphy RJ, Zhu Y, Schulick RD. Immunotherapy for pancreatic cancer: barriers and breakthroughs. Annal Gastroenterol Surg. 2018;2:274–8. doi:10.1002/ags3.12176.
   PubMed Web of Science ®Google Scholar
• Dougan SK. The pancreatic cancer microenvironment. Cancer J. 2017;23:321–325. doi:10.1097/PPO.0000000000000288.
   PubMed Web of Science ®Google Scholar
• Bachem MG, Schünemann M, Ramadani M, Siech M, Beger H, Buck A, Zhou S, Schmid-Kotsas A, Adler G. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology. 2005;128:907–921. doi:10.1053/j.gastro.2004.12.036.
   PubMed Web of Science ®Google Scholar
• Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21:418–429. doi:10.1016/j.ccr.2012.01.007.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Ehata S, Koinuma D, Morishita Y, Soda M, Mano H, Miyazono K. Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells. Oncogene. 2018;37:2757–2772. doi:10.1038/s41388-018-0144-0.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Modi S, McGinn O, Zhao X, Dudeja V, Ramakrishnan S, Saluja AK. Impaired synthesis of stromal components in response to minnelide improves vascular function, drug delivery, and survival in pancreatic cancer. Clin Cancer Res. 2016;22:415–425.
   Google Scholar
• Amedei A, Niccolai E, Benagiano M, Della Bella C, Cianchi F, Bechi P, Taddei A, Bencini L, Farsi M, Cappello P, et al. Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions. Cancer Immunol Immunother. 2013;62:1249–1260. doi:10.1007/s00262-013-1429-3.
   PubMed Web of Science ®Google Scholar
• Feig C, Jones JO, Kraman M, Wells RJ, Deonarine A, Chan DS, Connell CM, Roberts EW, Zhao Q, Caballero OL, Teichmann SA. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer. Proceedings of the National Academy of Sciences. 2013 Dec 10;110(50):20212-7.
   Google Scholar
• Garg B, Giri B, Modi S, Sethi V, Castro I, Umland O, Ban Y, Lavania S, Dawra R, Banerjee S, et al. NFκB in pancreatic stellate cells reduces infiltration of tumors by cytotoxic T cells and killing of cancer cells, via up-regulation of CXCL12. Gastroenterology. 2018;155:880–891.e888. doi:10.1053/j.gastro.2018.05.051.
   PubMed Web of Science ®Google Scholar
• Nummer D, Suri-Payer E, Schmitz-Winnenthal H, Bonertz A, Galindo L, Antolovich D, Koch M, Büchler M, Weitz J, Schirrmacher V, et al. Role of tumor endothelium in CD4+CD25+ regulatory T cell infiltration of human pancreatic carcinoma. JNCI. 2007;99:1188–1199. doi:10.1093/jnci/djm064.
   PubMed Web of Science ®Google Scholar
• Landry J, Bernier D, Chrétien P, Nicole LM, Tanguay RM, Marceau N. Synthesis and degradation of heat shock proteins during development and decay of thermotolerance. Cancer Res. 1982;42:2457–2461.
   PubMed Web of Science ®Google Scholar
• Radons J. The human HSP70 family of chaperones: where do we stand? Cell Stress Chaperones. 2016;21:379–404.
   PubMed Web of Science ®Google Scholar
• Aghdassi A, Phillips P, Dudeja V, Dhaulakhandi D, Sharif R, Dawra R, Lerch MM, Saluja A. Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res. 2007;67:616–625. doi:10.1158/0008-5472.CAN-06-1567.
   PubMed Web of Science ®Google Scholar
• Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC, Wilson JS. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut. 1998;43:128–133. doi:10.1136/gut.43.1.128.
   PubMed Web of Science ®Google Scholar
• Rooijen NV, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174:83–93. doi:10.1016/0022-1759(94)90012-4.
   PubMed Web of Science ®Google Scholar
• Majumder K, Arora N, Modi S, Chugh R, Nomura A, Giri B, Dawra R, Ramakrishnan S, Banerjee S, Saluja A. A novel immunocompetent mouse model of pancreatic cancer with robust stroma: a valuable tool for preclinical evaluation of new therapies. J Gastrointestinal Surg. 2016;20:53–65.
   PubMed Web of Science ®Google Scholar
• Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, Zhang S, Bettigole SE, Gupta D, Holcomb K, et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell. 2015;161:1527–1538. doi:10.1016/j.cell.2015.05.025.
   PubMed Web of Science ®Google Scholar
• Gabai VL, Yaglom JA, Wang Y, Meng L, Shao H, Kim G, Colvin T, Gestwicki J, Sherman MY. Anticancer effects of targeting Hsp70 in tumor stromal cells. Cancer Res. 2016;76:5926–5932. doi:10.1158/0008-5472.CAN-16-0800.
   PubMed Web of Science ®Google Scholar
• Escors D, Gato-Cañas M, Zuazo M, Arasanz H, García-Granda MJ, Vera R, Kochan G. The intracellular signalosome of PD-L1 in cancer cells. Signal Transduction Targeted Ther. 2018;3:26. doi:10.1038/s41392-018-0022-9.
   PubMed Web of Science ®Google Scholar
• Jiang N, Qiao G, Wang X, Morse MA, Gwin WR, Zhou L, Song Y, Zhao Y, Chen F, Zhou X, et al. Dendritic cell/cytokine-induced killer cell immunotherapy combined with S-1 in patients with advanced pancreatic cancer: a prospective study. Clin Cancer Res. 2017;23:5066–5073. doi:10.1158/1078-0432.CCR-17-0492.
   PubMed Web of Science ®Google Scholar